key: cord-0982451-nf9mhl0v
authors: Tan, Guoliang; Lian, Xihua; Zhu, Zhixing; Wang, Zhenhua; Huang, Fang; Zhang, Ying; Zhao, Yanping; He, Shaozheng; Wang, Xiali; Shen, Haolin; Lyu, Guorong
title: Use of lung ultrasound to differentiate COVID-19 pneumonia from community-acquired pneumonia
date: 2020-06-05
journal: Ultrasound Med Biol
DOI: 10.1016/j.ultrasmedbio.2020.05.006
sha: 1bc166839e4fbbaf874f888608c29dc0230cea83
doc_id: 982451
cord_uid: nf9mhl0v

To investigate the feasibility of lung ultrasound in evaluating coronavirus disease 2019 (COVID-19) and distinguish the sonographic features between COVID-19 and community-acquired pneumonia (CAP), a total of 12 COVID-19 patients and 20 CAP patients were selected and underwent the lung ultrasound. Modified Buda scoring system for interstitial lung disease (ILD) was used to evaluate the severity and treatment effect of COVID-19 on ultrasonography. The differences between modified lung ultrasound (MLUS) score and high-resolution computed tomography (HRCT) Warrick score were analyzed to evaluate their correlation. COVID-19 showed the following sonographic features: thickening (12/12), blurred (9/12), discontinuous (6/12) pleural line; rocket sign (4/12), partially diffused B-line (12/12), completely diffused B-line (10/12), waterfall sign (4/12); C-line sign (5/12); pleural effusion (1/12), and pulmonary balloon (Am line, 1/12). The last two features were rarely seen. Differences of ultrasonic features, including lesion range, lung signs and pneumonia-related complications, between COVID-19 and CAP were statistically significant (P<0.05 or 0.001). MLUS scores (P=0.006) and HRCT Warrick scores (P=0.015) increased as the severity of COVID-19 increased. The differences between moderate [29.00(25.75-37.50)] and severe [43.00(38.75-47.25)] (P=0.022) or between moderate and critical [47.50(44.25-50.00)] (P=0.002) type COVID-19 were statistically significant, compared with those between severe and critical types. Correlation between MLUS scores and HRCT Warrick scores was positive (r=0.54, P=0.048). MLUS scores (Z=2.61, P=0.009) and HRCT Warrick scores (Z=2.63, P=0.009) of five severe or critical COVID-19 patients significantly decreased as their conditions improved after treatment. The differences of sonographic features between COVID-19 and CAP patients were notable. The MLUS scoring system could be used to evaluate the severity and treatment effect of COVID-19.

Coronavirus disease 2019 refers to a type of pneumonia infected by SARS-CoV-2 which has swept the globe. COVID-19 is a newly identified category B infectious disease based on the infectious disease classification system of Chinese Center for Disease Control and Prevention, with the characteristics of infectivity, concealment and a long incubation period (Jin et al. 2020) . COVID-19 always occurs in a dense crowd and may cause fatal infection . Lethal COVID-19 is found more common in patients with underlying diseases such as hypertension, diabetes, cardiovascular diseases and respiratory diseases (The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020). COVID-19 poses a severe threat to human health. It is reported that early diagnosis and timely intervention can obviously reduce the incidence of severe COVID-19 patients and 4 prevent the progress of COVID-19 to critical condition (Jin et al. 2020) .

Early clinical diagnosis of COVID-19 depended on the real-time fluorescence quantitative reverse transcription-polymerase chain reaction detection of virus nucleic acids (Jin et al. 2020) . However, it is difficult to diagnose or follow up the geographically dispersed COVID-19 patients in critical condition by chest CT scan.

Studies have demonstrated that point-of-care ultrasound (POCUS) which is portable, flexible and free of ionizing radiation plays an important role in emergency and intensive care medicine (Volpicelli et al. 2012; Lichtenstein 2014) , and can be applied for semi-quantitative assessment of the severity of pulmonary edema and interstitial lung disease (ILD) (Zeng et al. 2019a (Zeng et al. , 2019b Zhu et al. 2020) . However, it is imperative to find out how to semi-quantitatively diagnose COVID-19 in an early stage and make a differential diagnosis from other types of pneumonia (Tsung et al. 2012 ). The histological changes in viral pneumonia are mainly characterized by interstitial lesions accompanied by lymphocyte infiltration, and often pulmonary interstitial fibrosis in the advanced stage (Shen et al. 2003) . Since ultrasound has been widely used in the diagnosis and differentiation of interstitial pulmonary abnormalities (Volpicelli et al. 2012; Lichtenstein 2014) , we hypothesized that ultrasound could be used to differentiate COVID-19 from community-acquired pneumonia (CAP).

This clinical study protocol was reviewed and approved by the Institutional 5 Review Board and the Ethics Committee of Quanzhou Medical College, Fujian, China (2019-10). Informed consent was obtained from every patient or their assignee for this research and to publish paper which is focused on their data and images.

A total of 12 confirmed COVID-19 patients were selected as subjects, including 4 males and 8 females ranging from 52 to 79 years old, with a median age of 60.5. All patients met the new diagnostic criteria for coronavirus pneumonia issued by the National Health Commission of the People's Republic of China. COVID-19 was divided into 4 clinical types: mild, moderate, severe, and critical (Table 1) (Jin et al. 2020 ). Among the 12 cases, there were 4 with moderate type, 4 severe type, and 4 critical type. All patients underwent chest CT examination as part of the diagnosis.

There were 4 patients with underlying diseases, including 1 with hypertension, 1 with diabetes, and 2 with cardiovascular diseases. After half a month of treatment, five patients improved from severe or critical type to moderate type ( Table 2 ). The data were collected from Wuhan Jinyintan Hospital from January 20 to February 20, 2020.

A total of 20 confirmed CAP patients were enrolled as control group, including 8 males and 12 females ranging from 48 to 76 years old, with a median age of 57.5. Scoring system for lung ultrasound All patients were examined and evaluated by ICU physicians who have received ultrasound training and obtained qualifications, and if necessary, videos were recorded for remote consultation. The modified lung ultrasound (MLUS) scoring system used in this study was modified based on the ILD Buda scoring system (Buda et al. 2016) and high-resolution computed tomography (HRCT) Warrick scoring system with a maximum score of 60 points (Table 3 ). The scoring system mainly consisted of three items: (1) pleural line involvement, including thickened, blurred, irregular or discontinuous pleural line; (2) lung parenchymal involvement, including B-line, partially diffused B-line, completely diffused B-line (white lung) and lung consolidation; (3) complications, including pneumothorax, emphysema, and pleural effusion. Pleural line, pulmonary parenchyma and complications were observed and 8 scored respectively in each section. There were 10 sections of bilateral lungs, the pleural line score less than 18 points, the lung score less than 34 points, the complication score less than 8 points.

Chest CT was carried out for all patients in this study in accordance with the standard protocol with a 64-row multidetector CT scanner (Somatom Perspective; Siemens, Germany). Scan ranged from the apex to the base of the lung with a HRCT scanning parameter of 120 HV, automatic mAs, 1.0 mm slice thickness, 0.90 pitch, and field of view 30-40 cm. Lung window imaging was reconstructed with high-frequency algorithm (width, 1600Hu; level, -600Hu).

CT examination and scoring system Chest CT scan was performed for all patients. Warrick's CT scoring criteria (Buda et al. 2016 ) was used to score the semi-quantitative chest CT scan in this study (Table 4 ). The CT results were evaluated by experienced CT imaging physicians in a blind fashion.

Continuous variables were expressed as medians (quartile 1 -quartile 3), and categorical variables were expressed as counts and percentages. Wilcoxon rank sum tests for continuous variables and chi-square or Fisher exact tests (where possible) for categorical variables were used to compare differences of test variables between the groups. Pearson correlation was applied to analyze the correlation between MLUS score and HRCT Warrick score. Probability values of < 0.05 were considered statistically significant. All data analyses were performed with commercially available statistical analysis software packages (SSPS 15.0; SSPS, Chicago, IL).

The main sonographic features of COVID-19 were as follows: (1) Differences in sonographic features between COVID-19 and CAP were shown in Table 5 . Table 7 .

POCUS has found its wide application in emergency and critical care medicine (Volpicelli et al. 2012; Lichtenstein 2014) . Many studies (Volpicelli et al. 2012; Lichtenstein 2014; Reissig et al. 2012; Alzahrani et al. 2017 ) have shown that ultrasound imaging is more sensitive than chest X-ray examination in the diagnosis of ventilator-associated pneumonia (Mongodi et al. 2016 ) and CAP (Ho et al. 2015) . It can also make a sensitive diagnosis of viral pneumonia such as H1N1 or H7N9 earlier than chest X-ray examination (Ho et al. 2015; Testa et al. 2012 ) and thus has been recommended as an alternative screening method for such pneumonia in endemic 11 areas (Testa et al. 2012; Tsai et al. 2014; Lissaman et al. 2019). However, ultrasound identification between viral pneumonia and bacterial pneumonia remains a huge challenge. This study indicated that ultrasound was feasible in the diagnosis of COVID-19, and the ultrasound images were mainly manifested as B-line artifact, rocket sign, and partially or completely diffused B-line. Small consolidation and abnormal pleural line were detected in some cases. Noticeable differences in sonographic features were shown between COVID-19 and CAP. Ultrasound images of CAP were often manifested as large and circumscribed consolidation accompanied by bronchial gas phase or liquid phase, and pleural effusion was more common in CAP patients while their lung lesions were, to some extent, limitedly distributed when compared with those of COVID-19 patients. Consolidations were more extensive in bacterial pneumonia because a large number of fibrinogens permeated out from blood vessel to alveoli as the permeability of the blood vessel increased. Lung tissue was completely degassed and performed as a solid tissue echo in ultrasound which was described as varying sizes of "hepatic-like changes". Consolidations usually occurred in lung segment or sub-segment and might be accompanied by bronchial gas phase or liquid phase. Viral pneumonia such as severe acute respiratory syndrome (SARS) was histologically characterized by interstitial pneumonia with lymphocytes infiltration.

The inflammation originated from bronchi and bronchioles, then pulmonary interstitial exudation, lymphedema, and interstitial lung fibrosis emerged along the walls of bronchi, bronchiole and alveolus as well as the space among lobes.

Consolidations can be detected in such areas in severe patients. Viral pneumonia could be easily distinguished from bacterial pneumonia by ultrasound with the pathological differences. A limited number of studies (Tsung et al. 2012) showed that the pathologic features of COVID-19 were mainly manifested by diffused interstitial inflammation alveolar damage, including apoptosis and shedding of alveolar epithelial cells, formation of pulmonary hyaline membrane, obviously widened lobar space and infiltration of inflammatory cells composed of lymphocytes and monocytes. The similar pathological features among COVID-19, SARS and Middle East Respiratory Syndrome (Shen et al. 2003; Xu et al. 2020) were the pathological basis for the formation of lung ultrasound signs among patients with such diseases. The unique ultrasound signs of interstitial pneumonia included the disappearance of pleural line and the overlapping of B line, as well as white lung, waterfall sign, and small consolidations in severe patients with interstitial pneumonia. Combined with other studies, this study indicated that different viral pneumonias had the similar sonographic features, and there was still no evidence of obvious identification characteristics among them. However, compared with pulmonary edema and interstitial lung fibrosis, diffused B line or even waterfall sign were more commonly detected in COVID-19 patients. The reasons might be that the more severe pulmonary inflammation and more abundant mucus were conducive to the formation and fusion of B line in such patients (Volpicelli et al. 2012; Zeng et al. 2019a Zeng et al. , 2019b Zhu et al. 2020; Xu et al. 2020) . Unexpectedly, large consolidation was rarely seen in COVID-19, either bronchial fluid phase or gas phase was rarely seen in the consolidation, whereas nearly all the pleural abnormalities were detected in this study.

Many studies (Buda et al. 2016) indicated that lung ultrasound can be applied to the semi-quantitative evaluation of severity of pulmonary interstitial fibrosis. To meet the clinical needs of emergency and critical care ultrasound, BLUE-plus protocol was adopted to assess COVID-19 interstitial inflammation and fibrosis. Only 10 points (10 sections) were used for the observation of the pleural line, lung and thorax in the procedure, which significantly saved the evaluation time. Meanwhile, the Buda scoring system was modified (Table 1) patients. The results showed that the scores of lung abnormalities, calculated by the modified Buda scoring system, increased as the severity of COVID-19 increased, and there was a moderate correlation between MLUS scores and Warrick scores that were calculated by HRCT scoring method. Therefore, this new semi-quantitative pulmonary ultrasound assessment may be a viable approach for the evaluation of severity of interstitial pneumonia including COVID-19. Furthermore, the study suggested that this new semi-quantitative method can also be used to evaluate the treatment effects of methods (such as CT) for COVID-19 during the follow-up. It is worth mentioning that this study also indicated that the MLUS scoring system is better in distinguishing moderate group from severe or critical group, compared with HRCT which has an advantage in identifying severe or critical group. This should be emphasized in the clinical application of MLUS scoring system.

There are some limitations in this study. 1. Sample size of this study was small. 2.

Mild COVID-19 patients were not included. 3. LUS was performed either in ICU or isolated ward, obtaining high quality images was not allowed due to the emergent situations and poor-quality imaging system. More studies on prospective design are needed in the future.

In summary, ultrasound imaging is a really effective choice for the evaluation of pulmonary abnormalities during the epidemic. Several different sonographic features between COVID-19 and CAP patients have been demonstrated in this study. MLUS scoring system is helpful for the evaluation of severity of COVID-19, while POCUS plays a valuable role as an adjunct tool to HRCT in the assessment of COVID-19 patients. Table 1 Main clinical features of different COVID-19 types Table 2 Clinical data of 5 COVID-19 patients who improved from severe or critical type to moderate type 22 Note: "Improve to moderate type" means that patients have no dyspnea and oxygen inhalation, and show normal liver and kidney functions. 

Systematic review and meta-analysis for the use of ultrasound versus radiology in diagnosing of pneumonia

Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis

Lung Ultrasonography in the Evaluation of Interstitial Lung Disease in Systemic Connective Tissue Diseases: Criteria and Severity of Pulmonary Fibrosis -Analysis of 52 Patients

Usefulness of lung ultrasound in the diagnosis of community-acquired pneumonia in children

Research Team E-BMCoCIE, Promotive Association for M, Health C. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Lung ultrasound in the critically ill

Prospective observational study of point-of-care ultrasound for diagnosing pneumonia

Diagnosis and treatment of adults with community-acquired pneumonia

Lung ultrasound for early diagnosis of ventilator-associated pneumonia

Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study

Pathological diagnosis and differential diagnosis of severe acute respiratory syndrome

Early recognition of the 2009 pandemic influenza A (H1N1) pneumonia by chest ultrasound

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Lung ultrasound imaging in avian influenza a (H7N9) respiratory failure

Prospective application of clinician-performed lung ultrasonography during the 2009 H1N1 influenza a pandemic: distinguishing viral from bacterial pneumonia

Copetti 18

International evidence-based recommendations for point-of-care lung ultrasound

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

In vitro experimental study for the formation mechanism of B line in lung ultrasound

Study on the correlation between B Line in ultrasound and severity of pulmonary edema

Point-of-Care Ultrasound-A New Option for Early Quantitative Assessment of Pulmonary Edema

A: upper blue point (1), lower blue point (2); B: phrenic point (3), PLAPS-point (4); C: posterior blue point